Compare Gujarat Kidney with Similar Stocks
Total Returns (Price + Dividend) 
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025
15-Feb-2026 | Source : BSEStatement of deviation and variation for 31 december 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
15-Feb-2026 | Source : BSEIntimation under Regulation 30 under LODR regulation 2015 we would like to inform you that we received order from NCLT Ahmedabad under section 131 of the Companies Act 2013.
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025
14-Feb-2026 | Source : BSEOutcome of Board meeting held on 14th February 2026 for the approval of unaudited financial result standalone and consolidated of the company for quarter and nine months ended December 312025 and other business matters.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 9 FIIs (10.47%)
Pragnesh Yashwantsinh Bharpoda (38.16%)
Craft Emerging Market Fund Pcc-citadel Capital Fund (3.89%)
11.57%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 1.24% vs 13.28% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 1.30% vs 4.07% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






